Table 1.
Anatomy on phases of a diagnostic test.
Phase | What? | Design |
---|---|---|
I | Determination of normal ranges (pharmacokinetics, pharmacodynamics, and safe doses) | Observational studies on healthy subjects |
| ||
II | Evaluation of diagnosis accuracy | Case-control studies on healthy subjects and subjects with the known (by a gold standard test) and suspected disease of interest (i) Phase IIa: healthy subjects and subjects with the known disease of interest, all diagnosed by a gold standard method (ii) Phase IIb: testing the relevance of the disease severity (evaluate how a test works in ideal conditions) (iii) Phase IIc: assess the predictive values among subjects with suspected disease |
| ||
III | Evaluation of clinical consequences (benefic and harmful effects) of introducing a diagnostic test | Randomized control trials, randomization determine whether a subject receive or not the diagnosis test |
| ||
IV | Determination of the long-term consequences of introducing a new diagnostic test into clinical practice | Cohort studies of consecutive participants to evaluate if the diagnostic accuracy of a test in practice corresponds to predictions from systematic reviews of phase III trials |
Adapted from [7].